06.04.2013 Views

toxicological profile for malathion - Agency for Toxic Substances and ...

toxicological profile for malathion - Agency for Toxic Substances and ...

toxicological profile for malathion - Agency for Toxic Substances and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

MALATHION 125<br />

3. HEALTH EFFECTS<br />

Target Tissues. This model does not attempt to estimate the level of active toxic molecular species at<br />

the target tissues or at any other tissue. Instead, the goal of the model, <strong>for</strong> which validation <strong>and</strong><br />

optimization have been conducted, is to predict the dose based on the end product of metabolism. While<br />

the model incorporates kinetic constants <strong>for</strong> metabolic processes, the main elements that controlled the fit<br />

of output with actual data appear to be skin permeability constants (Dong et al. 1996), <strong>and</strong> <strong>for</strong> the purpose<br />

of this model, other internal elements appear less important <strong>and</strong> hence less suited <strong>for</strong> predictions of target<br />

tissue levels of the toxicant.<br />

Species Extrapolation. Although some parameters <strong>and</strong> constants have been adapted from rodent data,<br />

the model has been <strong>for</strong>mulated <strong>for</strong> human simulation from the outset <strong>and</strong> reverse extrapolation to animals,<br />

while useful, has not been tested.<br />

Interroute Extrapolation. This model has been optimized solely <strong>for</strong> the purpose of estimating dermal<br />

doses. As stated above under “Target Tissues”, internal elements have not been optimized. Further<br />

validation <strong>and</strong> adjustments will be needed <strong>for</strong> the model to be useful in oral or inhalation routes of<br />

exposure.<br />

3.5 MECHANISMS OF ACTION<br />

The typical acute neurotoxic action of <strong>malathion</strong> is cholinergic. It involves the inhibition of the neural<br />

acetylcholinesterase by its active metabolite, malaoxon (Ecobichon 1994). The inhibition occurs due to<br />

the similarity of malaoxon to the neurotransmitter acetylcholine. Mimicking acetylcholine, malaoxon<br />

first binds to the active serine residue of acetylcholinesterase, undergoes a double displacement reaction<br />

involving the serine hydroxyl group, <strong>and</strong> yields dimethyl-phosphorylated acetylcholinesterase. Since the<br />

phosphorylated acetylcholineterase is stable within the time frame of poisoning, the inhibition prevents<br />

the normally extremely rapid hydrolysis of neurotransmitter acetylcholine, prolonging the impulse<br />

transmission.<br />

The expression of toxic signs depends on which of the divisions of nervous systems is affected. Thus,<br />

commonly observed cholinergic signs of poisoning including salivation, lacrimation, perspiration, <strong>and</strong><br />

constriction of the pupils are due to the stimulation of muscarinic acetylcholine receptors in the<br />

parasympathetic autonomic synapse at exocrine gl<strong>and</strong>s <strong>and</strong> eyes. Other consequences of stimulating

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!